Susman Robert Graham has filed 5 insider transactions across 1 company since May 2025.
Most recent transaction: a sale of 2502 shares of Immunovant, Inc. ($IMVT) on May 01, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Immunovant, Inc. | $IMVT | Susman Robert Graham | Director | S | Common Stock | 2502 | $27.17 | 36,394.0000 | 203,532,180 | 6.43% | 0.00% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Susman Robert Graham | Director | A | Common Stock | 13880 | $0.00 | 38,896.0000 | 203,532,180 | 55.48% | 0.01% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Susman Robert Graham | Director | A | Stock Option (right to buy) | 7061 | $0.00 | 7,061.0000 | 203,532,180 | 9999.99% | 0.00% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Susman Robert Graham | Not found | A | Common Stock | 25016 | $0.00 | 25,016.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Susman Robert Graham | Not found | A | Stock Option (Right to Buy) | 35234 | $0.00 | 35,234.0000 | 0 | 9999.99% | 0.00% |